Statement Of Cash Flows [Abstract]

LNA Santé - Filing #5981498

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities	13 787 EUR	—	—	273,000 EUR	13 514 EUR	—	10 270 EUR	—	9 849 EUR	—	—	421,000 EUR
Cash flows from (used in) operating activities	110 439 EUR	—	—	18 443 EUR	128 882 EUR	—	97 504 EUR	—	137 499 EUR	—	—	39 995 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities	103,000 EUR	—	—	—	—	—	101,000 EUR	—	—	—	—	—
Proceeds from sales of intangible assets, classified as investing activities	1 825 EUR	—	—	—	—	—	- EUR	—	—	—	—	—
Dividends received, classified as investing activities	203,000 EUR	—	—	—	—	—	210,000 EUR	—	—	—	—	—
Cash flows from (used in) investing activities	23 722 EUR	—	—	1 199 EUR	22 523 EUR	—	15 689 EUR	—	12 819 EUR	—	—	2 870 EUR
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities	59 353 EUR	—	—	—	—	—	57 250 EUR	—	—	—	—	—
Interest paid, classified as financing activities	28 580 EUR	—	—	—	—	—	26 654 EUR	—	—	—	—	—
Cash flows from (used in) financing activities	88 802 EUR	—	—	18 388 EUR	107 190 EUR	—	106 685 EUR	—	146 273 EUR	—	—	39 588 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	2 084 EUR	—	—	1 254 EUR	831,000 EUR	—	24 870 EUR	—	21 594 EUR	—	—	3 277 EUR
Cash and cash equivalents	—	75 055 EUR	74 303 EUR	—	—	752,000 EUR	—	77 170 EUR	—	75 176 EUR	1 994 EUR	—